ESC 365 - Optimal duration of dual antiplatelet therapy study after ACS.

ACVC Premium Access

Optimal duration of dual antiplatelet therapy study after ACS.

Session: Dilemmas in anti thrombotic therapy

Topic: Antithrombotic agents

Speaker: Professor J. Morais (Leiria, PT)

Event: Acute Cardiovascular Care 2016

Congress Presentation

Add to my library

About the speaker

Professor Joao Morais

Leiria Hospital Centre, Leiria (Portugal)

18 presentations

0 follower

3 more presentations in this session

New tools to manage bleeding under NOACS.

Speaker: Professor K. Huber (Vienna, AT)

To pre treat or not to pre treat in ACS?

Speaker: Associate Professor S. Matetzky (Ramat Gan, IL)

Anti thrombotic choices after bleeding.

Speaker: Professor S. Halvorsen (Oslo, NO)

Access the full session

Dilemmas in anti thrombotic therapy

Speakers: Professor J. Morais, Professor K. Huber, Associate Professor S. Matetzky, Professor S. Halvorsen

About the event

Acute Cardiovascular Care 2016

15 October - 17 October 2016

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources